<DOC>
	<DOC>NCT01733420</DOC>
	<brief_summary>A clinical trial to evaluate and compare three different products used for endodontic treatment (taking the infected nerve out of the teeth) of primary teeth. Null Hypothesis: The new biological products (WMTA and Biodentine) behave as good as the former iodoform product.</brief_summary>
	<brief_title>Biodentine Versus White MTA Pulpotomy</brief_title>
	<detailed_description />
	<criteria>Patients (Children with carious deciduous molars indicated for pulpotomy) belonging to the category of ASA I according to the 'American Society of Anaesthesiologists'. Patients without any known medical history of systemic complications contradicting pulp treatment. Patients are indicated for treatment under general anaesthesia due to polycaries / fear / anxiety / very young age. Written consent is obtained from the parent/guardian after explaining the full details of the treatment procedure and its possible outcomes.</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>9 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>